Alejo Chorny

Alejo Chorny is a distinguished biotechnology professional with extensive experience in scientific leadership and business development. Currently serving as Co-Founder and Chief Scientific Officer at Orikine Bio since September 2022, Alejo plays a pivotal role in advancing engineered cytokines for immune-mediated disease therapies. As Operating Partner and Head of Spanish Operations at AdBio Partners, Alejo focuses on early-stage therapeutics investments. Previously, Alejo held the position of Chief Operating Officer at Ribonexus, overseeing the development of innovative cancer therapies. Alejo has also contributed to BIAL's business development and served as a consultant at Celdara Medical. With a robust academic background that includes a Ph.D. in Immunology from Universidad de Granada and postdoctoral research at Icahn School of Medicine at Mount Sinai, Alejo blends scientific expertise with strategic insights in the biotech sector.